机器学习用于个体化预测抗病毒治疗根除丙型肝炎病毒后肝细胞癌的发生
这项多中心队列研究纳入1742例获得持续病毒学应答的慢性丙型肝炎患者,开发了五种机器学习模型预测肝细胞癌发生,并在977例独立队列中外部验证。随机生存森林模型使用7个参数区分度最佳,外部验证c-index为0.839,可将患者分为三个风险组(P<0.001),并可通过在线应用生成个体化预测曲线。
要点
- 随机生存森林模型使用7个参数预测持续病毒学应答后肝细胞癌,外部验证c-index为0.839。
- 该模型可将患者分为三个风险组,组间区分能力高(P<0.001)。
- 模型可生成个体化预测曲线,在线应用已可用。
核心结论
- 开发并外部验证了随机生存森林模型,对持续病毒学应答后肝细胞癌风险具有良好预测性能。
- 该新型模型的应用可在网站上获取。
- 该模型可提供数据以考虑有效的监测方法,但需进一步研究才能为各国医疗情况量身定制监测政策提出推荐。
研究设计与样本
- 多中心队列研究,纳入1742例获得持续病毒学应答的慢性丙型肝炎患者。
- 开发了五种机器学习模型,包括DeepSurv、梯度提升生存分析、随机生存森林、生存支持向量机和传统Cox比例风险模型。
- 模型性能用Harrell c-index评估,并在977例独立队列中外部验证。
主要发现
- 平均观察期5.4年,122例患者发生肝细胞癌(推导队列83例,外部验证队列39例)。
- 随机生存森林模型使用持续病毒学应答时的7个参数,外部验证队列c-index为0.839,区分能力最佳。
- 患者分为三个风险组时区分能力高(P<0.001)。
- 该随机生存森林模型可为每位患者生成肝细胞癌发生的个体化预测曲线,并有在线应用可用。
关键数值与推荐
- 随机生存森林模型使用7个参数,外部验证c-index为0.839。
- 三个风险组间区分能力高(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步研究才能为各国医疗情况量身定制监测政策提出推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Accurate risk stratification for hepatocellular carcinoma (HCC) after achieving a sustained viral response (SVR) is necessary for optimal surveillance. We aimed to develop and validate a machine learning (ML) model to predict the risk of HCC after achieving an SVR in individual patients. METHODS: In this multicenter cohort study, 1742 patients with chronic hepatitis C who achieved an SVR were enrolled. Five ML models were developed including DeepSurv, gradient boosting survival analysis, random survival forest (RSF), survival support vector machine, and a conventional Cox proportional hazard model. Model performance was evaluated using Harrel' c-index and was externally validated in an independent cohort (977 patients). RESULTS: During the mean observation period of 5.4 years, 122 patients developed HCC (83 in the derivation cohort and 39 in the external validation cohort). The RSF model showed the best discrimination ability using seven parameters at the achievement of an SVR with a c-index of 0.839 in the external validation cohort and a high discriminative ability when the patients were categorized into three risk groups (P <0.001). Furthermore, this RSF model enabled the generation of an individualized predictive curve for HCC occurrence for each patient with an app available online. CONCLUSIONS: We developed and externally validated an RSF model with good predictive performance for the risk of HCC after an SVR. The application of this novel model is available on the website. This model could provide the data to consider an effective surveillance method. Further studies are needed to make recommendations for surveillance policies tailored to the medical situation in each country. IMPACT AND IMPLICATIONS: A novel prediction model for HCC occurrence in patients after hepatitis C virus eradication was developed using machine learning algorithms. This model, using seven commonly measured parameters, has been shown to have a good predictive ability for HCC development and could provide a personalized surveillance system.
引用
- Minami T, Sato M, Toyoda H, et al. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals. J Hepatol. 2023. PMID: 37716372. doi:10.1016/j.jhep.2023.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。